With ample experience in psychiatric disease research, Creative Biolabs has become an incontestable
global leader in the psychotropic drug development market. Based on the advanced platform we have established,
Creative Biolabs is proud to offer high-quality omics tools for academic purposes to contribute significantly to the
success of your project. Our focus is to exceed your expectations while providing accurate and reliable services.
Omics Tools for Psychiatric Disease Research
Psychiatric disorders are common yet debilitating conditions. One area which offers great promise and potentially a
route to new treatments is the role of genetics in psychiatry. Using genetic information to define subpopulations
within the core diagnoses may also provide a route to better diagnosis and targeting of the most suitable
medication. For example, optogenetics and chemogenetics provide research tools to selectively target distinct
neuronal populations and pathways to investigate their role in behavior. These datasets reveal relationships of
neuropsychiatric risk genes to biology and find putative therapeutic targets.
Using proteomics to investigate distinct protein patterns is promising to improve the biology of psychiatric
disorders and identify biomarkers. Also, knowledge of biochemical pathways can provide disease marker information
for drug development and improved patient treatment. Therefore, proteomic research and metabonomics will hopefully
have a significant impact on developing treatments for psychiatric disorders.
Fig.1 Overview of
different omics-sciences. (Steuer, 2019)
Omics Tools Available at Creative Biolabs
Advances in omics approaches to mental illnesses provide the backdrop for new opportunities in drug development in
psychiatry. As a leading company in the psychiatric disease research market, experts in Creative Biolabs possess
enriched psychiatric drug development experience. We can offer many different technical platforms for our customers
and focus on ideal omics tools that meet the customers' specific requirements. Creative Biolabs is devoted to
tailoring the best-fit proposal and most suitable solution with expected functionalities to meet your objectives.
As more and more measures during drug action become available, integration of genetic, proteomic, metabolic, and
pharmacokinetic data can be utilized as tools developed for psychiatric disease research. If you have a project that
requires the expertise and knowledge in omics research tools for the psychiatric disease that we can provide, please
click the links below:
Based on our well-established platform, Creative Biolabs can provide first-class omics tools to
achieve your psychiatric drug development goal in a timely and cost-effective manner. We are always pleased to offer
the best service and the most qualified outcomes to meet your specific requirements. Please send us a note or give us a call to find out what we can do for you.
Reference
Steuer, A. E.; et al. Metabolomic strategies in biomarker research-New approach for indirect identification of drug consumption and sample manipulation in clinical and forensic toxicology? Frontiers in chemistry. 2019, 7: 319. Distributed under Open Access license CC BY 4.0, without modification.
Fig.1 Overview of
different omics-sciences. (Steuer, 2019)
